Vascular Medicine News

Cardiometabolic comorbidities, such as hypertension, cardiac arrythmias and diabetes, are more common in adults with acromegaly than those without the condition, according to a systematic review and meta-analysis published in Pituitary.

Asymptomatic metabolic syndrome at midlife was associated with increased risk and earlier occurrence of CV events and mortality later in life, researchers reported.

In patients with acute MI complicated by cardiogenic shock, use of early extracorporeal life support did not reduce risk for death at 30 days compared with medical therapy alone, researchers reported.

In patients aged 75 years or older with MI and multivessel CAD, physiology-guided complete revascularization improved outcomes compared with treating the culprit lesion only, according to the results of the FIRE trial.

Colchicine did not reduce risk for perioperative atrial fibrillation or myocardial injury vs. placebo after noncardiac chest surgery, but a speaker noted a slight trend toward protection from a composite of both outcomes.

In patients with device-detected atrial high-rate episodes, treatment with edoxaban did not reduce ischemic events and increased risk for a composite of death and major bleeding compared with placebo, researchers reported.

Use of recreational drugs such as cannabis, opioids, cocaine and amphetamines was prevalent in 11% of patients admitted to French cardiac ICUs and tied to increased odds of in-hospital major adverse events, researchers reported.

A slim majority of FDA advisory panelists rejected that the benefits of a radiofrequency renal denervation system outweigh the risks for use in adults with uncontrolled hypertension despite use of antihypertensive medications.

DANA POINT, Calif. — Peripheral artery disease remains underdiagnosed and undertreated among women worldwide and efforts are needed to increase awareness, improve diagnoses and ensure patient referrals, according to a speaker.

An FDA advisory panel voted 10-2 that the benefits of an ultrasound renal denervation system outweigh the risk for use in adults with uncontrolled hypertension who are unresponsive or intolerant to antihypertensive medications.